Monday, November 23, 2009

Health

Science & Society

Posted 4/18/04

Tuneups For Misfiring Neurons

Two different classes of medicine are prescribed for people with ADD/ADHD: stimulants that focus on the dopamine transmitters and nonstimulants that hit the norepinephrine system. But why give a stimulant to someone who is hyperactive?

There are three subtypes of the disorder: hyperactive, inattentive, and a combination of the two. Each version is likely to involve deficiencies in dopamine and norepinephrine activity along the pathways between the basal ganglia and the prefrontal cortext, which control attention and short-term memory. The cells that transport both dopamine and norepinephrine may be working overtime in people with the disorder, sucking up the neurotransmitters that are essential for smooth mental functioning. Some stimulant medications like methylphenidate (Ritalin, Concerta, and Metadate) may slow down that vacuum cleaner and increase the amount of available dopamine. Others, like the amphetamines (Dexedrine, Adderall), simply increase the amount of available dopamine so that even overactive vacuum cells can't suck it all up. And the new nonstimulant medications, like Strattera, act on norepinephrine as Ritalin does on dopamine.

But stimulant medications are tightly restricted because they're considered potential drugs of abuse. Critics contend that these medications have not been well tested on children and could be dangerous, and some even believe that early use of stimulant medications could lead to later substance abuse. On the other hand, there are studies suggesting that unmedicated attention disorders can lead to self-medication and substance abuse. Side effects of the prescription medications--including sleep difficulties, headaches, and tics--while unpleasant, tend to be manageable.

Increasingly, doctors are being urged not to fall into what Thomas Spencer, an ADD expert at Massachusetts General Hospital, describes as the "apologetic model of treatment"--that is, the least amount of the drug over the shortest period of time. Medication for poor attention, he and others contend, is comparable to wearing glasses for poor vision: necessary all the time for nearly every aspect of life.

Biology of Confusion

The reigning theory is that attention deficits are related to faulty biochemical communication in the brain.

1 Normally, a thought or an idea causes a nerve impulse to travel down the axon to the synapse, where it triggers the release of chemical messenger molecules such as dopamine and norepinephrine.

2 These chemicals prompt communication along pathways between the basal ganglia, deep in the brain, and the frontal lobes of the thinking brain.

3 In ADD patients, this all goes askew. Dopamine and norepinephrine are sucked up by vacuum-like molecules, and thus cannot play their usual role in communicating thoughts.

[Drawing labels]

Neuron (2)

Area of detail

Basal ganglia

Prefrontal cortex

Axon

Vesicle sac

Dopamine

Synapse

Vacuumlike molecule

Surface of nearby neutron

Rod Little--USN&WR

-Marianne Szegedy-Maszak

Dazed, Famous

There are many areas in which those with attention deficit disorder are able to focus intensely and bring to bear the creativity and occasional genius associated with their racing brains. These figures show traits of attention disorder.

TERRY BRADSHAW

The former Steelers quarterback has ADHD and has overcome depression, too.

advertisement

advertisement

Symptom Search

American Hospital Association Symptom Finder

Discover possible causes of your symptoms.

NEWSLETTER

Sign up today for the latest headlines from U.S. News and World Report delivered to you free.

RSS FEEDS

Personalize your U.S. News with our feeds of blogs and breaking news headlines.

USNews MOBILE

U.S. News daily briefings are also available on your mobile device.

Use of this Web site constitutes acceptance of our Terms and Conditions of Use and Privacy Policy.